Back
Sarepta Therapeutics Stock Price Chart
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
$20.06
Seasonality Move:
13.55%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.67 | Sell |
| 20-day SMA: | 36.01 | Sell |
| 50-day SMA: | 44.57 | Sell |
| 200-day SMA: | 97.23 | Sell |
| 8-day EMA: | 29.12 | Sell |
| 20-day EMA: | 34.96 | Sell |
| 50-day EMA: | 46.57 | Sell |
| 200-day EMA: | 85.47 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.48 | Sell |
| Relative Strength Index (14 RSI): | 20.96 | Sell |
| Chaikin Money Flow: | -5078412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.42 - 42.02) | Sell |
| Bollinger Bands (100): | (39.94 - 101.08) | Sell |
Sarepta Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 20.77 while SRPT 8-day simple moving average is 31.67, which is a Sell signal.
-
The stock price of SRPT is 20.77 while Sarepta Therapeutics 20-day SMA is 36.01, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 44.57 while SRPT share price is 20.77, making it a Sell technically.
-
SRPT stock price is 20.77 and Sarepta Therapeutics 200-day simple moving average is 97.23, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $20.77. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
2B
Price in USD:
20.77
Share Volume:
7.5M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
18.30
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 20.77 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 20.77 while SRPT 8-day exponential moving average is 29.12, which is a Sell signal.
-
The stock price of SRPT is 20.77 while Sarepta Therapeutics 20-day EMA is 34.96, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 46.57 while SRPT share price is 20.77, making it a Sell technically.
-
SRPT stock price is 20.77 and Sarepta Therapeutics 200-day simple moving average is 85.47, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.61 per share, a decrease this year of $5.46 per share, and an increase next year of $5.87 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -5.48, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 20.96, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (30.42 - 42.02), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (39.94 - 101.08), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.